Drreddys Laboratories | RDY - Net Income


Drreddys Laboratories reported INR2.21B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Aurora Cannabis CAD -71.1M 72.92M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Canopy Growth CAD -157.11M 94.49M Mar/2026
Cipla INR 7.89B 2.34B Jun/2026
Corcept Therapeutics USD 42.14M 73.9M Jun/2026
Drreddys Laboratories INR 2.21B 9.89B Mar/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Novartis USD 3.26B 108M Jun/2026
Pacira USD 4.65M 1.74M Jun/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 53.93M 7.23M Mar/2026
Richter Gedeon HUF 65.28B 21.94B Mar/2026
Sun Pharmaceuticals INR 28.95B 1.81B Jun/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Teva Pharmaceutical Industries USD -576M 945M Jun/2026